The Utility of Functionally Relevant Signature Genes in Assessing the Clinical Outcomes of Dupilumab Treatment

Completed · Phase 4

Conditions studied: Atopic Dermatitis, Eczema

In brief

The utility of functionally relevant signature genes in assessing the clinical outcomes of dupilumab treatment in the adult onset atopic dermatitis

Key facts

Study ID

NCT04358224

Run by

Jonathan A. Bernstein, MD

People needed

12

Starts

2020-09-01

Expected to finish

2022-11-18

Last updated by the study team

2023-02-08

Who can join

Age: 19 and older, up to 75. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• history of adult onset atopic dermatitis

Where it is running

• Bernstein Clinical Research Center — Cincinnati, Ohio, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.